Invega Hafyera corresponds to which dosing formulation?

Unlock all questions

This demo includes only 20 questions. Upgrade to access hundreds of questions, flashcards, exam simulations, and disable ads.

Full question bankExam simulationsFlashcards
From $9.99Unlock all

Prepare for the Schizophrenia and Psychotic Disorders Test with interactive questions and detailed explanations. Equip yourself with the knowledge needed to excel in your exam!

Multiple Choice

Invega Hafyera corresponds to which dosing formulation?

Explanation:
Long-acting injectable antipsychotics come in different dosing intervals. Invega Hafyera is the six-monthly formulation of paliperidone palmitate, intended to be given every six months. This distinguishes it from the monthly paliperidone palmitate option and the three-monthly option, which are different products in the same paliperidone palmitate family. The other choices represent different drugs or different long-acting formulations (risperidone RBP-7000 and aripiprazole Maintena), not paliperidone palmitate six-monthly. So the six-monthly paliperidone palmitate formulation is the correct match.

Long-acting injectable antipsychotics come in different dosing intervals. Invega Hafyera is the six-monthly formulation of paliperidone palmitate, intended to be given every six months. This distinguishes it from the monthly paliperidone palmitate option and the three-monthly option, which are different products in the same paliperidone palmitate family. The other choices represent different drugs or different long-acting formulations (risperidone RBP-7000 and aripiprazole Maintena), not paliperidone palmitate six-monthly. So the six-monthly paliperidone palmitate formulation is the correct match.

More Multiple Choice Questions
Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy